Pre-approval Access for Janssen's COVID Vaccine VAC31518 for Treating Physician Use

Janssen (J&J Innovative Medicine)

Status

Conditions: Healthy

Treatments: Biological: Ad26.COV2.S

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT04817657

VAC31518COV4006 (Other Identifier)

CR109001

Details and patient eligibility

About

The purpose of this Pre-approval access (PAA) program is to provide VAC31518 (Ad26.CoV2.S) vaccine for the prevention of coronavirus disease-2019 (COVID-19) infection. This PAA program may be considered to protect participants against a serious/life-threatening diseases or conditions, where there are no alternative treatments available.

Sex

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria